While previous studies suggest that structural variants (SVs) play an important role in the development and progression of ADHD, these studies focused mostly on those of European ancestry and coding regions. This particular study seeks to address the role of SVs in non-European populations and outside of coding regions.
Individuals with attention-deficit/hyperactivity disorder (ADHD) face higher financial distress and subsequent suicide risk.
While the prevalence of attention-deficit/hyperactivity disorder is generally lower among Black individuals compared with the general population, black individuals living in countries where they are considered a minority population group are underrepresented in studies evaluating ADHD.
This study highlights the importance of transdiagnostic approaches to psychiatry.
Researchers conducted a retrospective study to assess self-injury behavior in patients with bipolar disorder and comorbid ADHD after initiation of a central stimulant.
Black individuals may be at higher risk for attention-deficit/hyperactivity disorder than the general US population.
An increased risk of ADHD-related behaviors was associated with exposure to select phthalates. Associations were strongest for phthalates with antiandrogenic activity.
SHP465 mixed amphetamine salts reduced symptoms of attention-deficit/hyperactivity disorder in adults, independent of ADHD treatment history.
A retrospective study was conducted to evaluate the demographic predictors of ADHD in hospitalized children with ASD and the impact of comorbidities on length of stay.
Investigators conducted a randomized clinical trial to assess the safety and efficacy of the investigational stimulant AR19 for the treatment of symptoms of attention-deficit/hyperactivity disorder in adults.
